- Hunter, Trooper, Scrappy and Buckaroo find zen by using
Zenrelia
- Newly published study in a leading peer-reviewed,
international journal, Veterinary Dermatology, compares clinical
outcomes between Zenrelia and Apoquel® (oclacitinib tablet)
GREENFIELD, Ind., Jan. 27, 2025 /PRNewswire/ -- Scratching,
rubbing, chewing, licking. All signs of an irritated, itchy dog.
With approximately 17 million U.S. dogs suffering from allergic
skin disease, including atopic dermatitis, food allergies or flea
sensitivity,i,ii these are the sounds too many pet
parents and veterinarians hear. Today, Elanco Animal Health
Incorporated (NYSE: ELAN), is introducing some of the first
allergic dogs who have found zen and gotten back to normal by using
Zenrelia. Zenrelia, which was approved by the U.S. Food and Drug
Administration (FDA) and launched in September 2024, is a highly effective, convenient
and safe once-daily oral JAK inhibitor for control of pruritus
(itching) associated with allergic dermatitis and control of atopic
dermatitis in dogs at least 12 months of age.
Experience the full interactive Multichannel News Release here:
https://www.multivu.com/elanco/9235451-en-elanco-zenrelia-canine-dermatology
"Our research shows that when pet owners see their dog at their
worst levels of itch, they're concerned, stressed, frustrated and
anxious,iii" said Bobby Modi, Executive Vice
President, U.S. Pet Health and Global Digital Transformation. "Pet
owners shouldn't allow allergic itch to disrupt zen for them or
their pups. Zenrelia is designed to begin working from the very
first doseiv and help get dogs back to
normal."v
In fact, a newly published study in a leading peer-reviewed,
international journal, Veterinary Dermatology, described the
findings of a randomized, clinical trial which compared Zenrelia to
the leading JAK inhibitor, Apoquel, in over 300 allergic dogs. The
full study findings can be found at:
https://doi.org/10.1111/vde.13319.
The Zenrelia label includes a boxed warning related to
concurrent vaccine administration based on the results of a vaccine
response study. It's important for veterinarians to read the entire
package insert, including the Boxed Warning, before prescribing
Zenrelia.
Meet Some of the Faces of Zen
According to a survey of
pet owners, itchy dog owners are eager to get back to a normal life
with their dogs, with 82% agreeing they dream of the day their
itchy dog becomes normal again and they understand that effective
treatment is part of that solution.ii With Zenrelia
now widely available, Zenrelia has expanded beyond the clinical
trial to helping dogs across the country—and their pet owners—find
zen. These real-world results give hope to millions of pet parents
whose pets suffer from itch.
Hunter from Ohio,
found his zen with Zenrelia. This eight-year-old Chocolate lab
suffered with dermatitis most of his life and as he got older, his
symptoms—especially licking at his feet and lower legs got worse.
His pet parent, Cristy, a receptionist at a vet clinic, tried
everything her veterinarian had recommended to bring Hunter relief.
Hunter had an extensive regimen of injections every 3-4 weeks,
medicated shampoos and wipes, antihistamines, and during parts of
the year when he was worse, he was on steroids. Even with this
intensive routine his symptoms were never fully controlled—until
Hunter took Zenrelia.
"His back feet were pretty much naked up until his first joint
and his front feet would be scabby and scaly from the constant
licking," Cristy said. "It was really discouraging as his dog mom
that I couldn't do anything to help him. He's so much more
comfortable since being on Zenrelia. It's such a relief that he has
relief."
According to Cristy, "It's worth talking to your veterinarian to
see if it's something that your dog would benefit from." Individual
results may vary and dogs should be up to date on vaccinations
prior to starting Zenrelia.
Trooper, a four-year-old Yorkshire Terrier, from
Arizona, first got back to normal
levels of itch when he participated in the Zenrelia clinical trial.
When the trial concluded, the itch returned. His owner, Robin, was
excited to get him back on the treatment now that Zenrelia is
widely available.
"Allergies are something he's going to have to suffer with his
whole life," said Trooper's pet parent, Robin. "Having a solution
for his allergies is such a relief. It makes my heart happy that I
will be able to afford it and give him the relief he deserves."
Lisa, pet mom to 9-year-old Yorkshire Terrier-Chihuahua mix
Scrappy said she "tried everything under the sun" to help
bring Scrappy relief. Scrappy's itching reached the point he lost a
significant amount of fur, he didn't want to play or go on walks
and no one was getting a good night's rest. Lisa tried numerous
treatment options and felt depleted knowing his itch was never
fully controlled, until she tried Zenrelia. After two days on
Zenrelia, his itch level improved and after eight weeks on
Zenrelia, Lisa is happy and relieved to see Scrappy back to a
normal dog. According to Lisa, his hair has re-grown, he's taking
long walks and he's a happy boy.
"I was excited to get Trooper, Scrappy and some other patients
started on Zenrelia as soon as it was available to order," said Dr.
Tom Lewis, veterinary dermatologist
and founder of Dermatology for Animals, a group of veterinary
dermatology clinics committed to caring for pets with allergies.
"Seeing these dogs get back to normal levels of itch and seeing the
bond restored between the dog and pet parents is incredibly
rewarding. Pet owners should contact their veterinarian and ask if
Zenrelia is right for their dog."
Buckaroo, an eight-year-old mixed breed from Texas, tried numerous treatment options
without relief, including steroids and immunotherapy–until his
veterinarian recommended Zenrelia. The photos show Buckaroo's skin
before Zenrelia, after three weeks of treatment, and after eight
weeks of treatment. His owner noted, "he's now the happiest boy in
the world and his energy levels have increased dramatically."
"I've had the opportunity to use Zenrelia in my practice and
it's helped several of my patients get back to normal levels of
itch," said Dr. Brittany
Lancellotti, a veterinary dermatologist at Veterinary
Skin and Ear in Los Angeles,
California. "In the fight against allergic dermatitis, I've
found that every dog is different - it's great to have another
effective treatment option in my toolbox."
"I work with dermatologists around the country through the
American College of Veterinary Dermatology," said Dr. Andrew Rosenberg, dermatologist, and director of
medical operations at Animal Dermatology Clinic in New York and President of the American College
of Veterinary Dermatology (ACVD). "It' great to have another tool
in the toolbox especially for both new and severe cases."
Veterinarians in the U.S. can learn more and place orders for
Zenrelia now at ZenreliaForVets.com.
ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader
in animal health dedicated to innovating and delivering products
and services to prevent and treat disease in farm animals and pets,
creating value for farmers, pet owners, veterinarians, stakeholders
and society as a whole. With 70 years of animal health heritage, we
are committed to breaking boundaries and going beyond to help our
customers improve the health of animals in their care, while also
making a meaningful impact on our local and global communities. At
Elanco, we are driven by our vision of Food and Companionship
Enriching Life and our Elanco Healthy Purpose™ sustainability
pillars – all to advance the health of animals, people, the planet
and our enterprise. Learn more at www.elanco.com.
INDICATIONS
Zenrelia is a prescription medication used to control itching
and inflammation associated with skin allergies for dogs over 12
months of age.
IMPORTANT SAFETY INFORMATION
See package insert including the Boxed Warning. For full
prescribing information speak with your veterinarian, call 1
888 545 5973 or visit www.elancolabels.com/us/zenrelia.
WARNING: VACCINE-INDUCED DISEASE AND INADEQUATE IMMUNE
RESPONSE TO VACCINES. Based on results of the vaccine response
study, dogs receiving Zenrelia are at risk of fatal vaccine-induced
disease and inadequate immune response to vaccines. Dogs should not
take Zenrelia for a time period before and after vaccination.
Discuss your dog's vaccine schedule with your veterinarian.
Dogs should be up to date on vaccinations prior to starting
Zenrelia. Do not use in dogs less than 12 months old or dogs with a
serious infection. Dogs should be monitored for the development of
infections because Zenrelia may increase the chances of developing
an infection. Neoplastic conditions (benign and malignant) were
observed during clinical studies. The most common side effects were
vomiting, diarrhea and tiredness. Zenrelia has not been tested in
dogs used for breeding, pregnant, or lactating dogs and has not
been evaluated in combination with glucocorticoids, cyclosporine,
or other immune suppressive drugs.
Zenrelia, Elanco and the diagonal bar logo are trademarks of
Elanco or its affiliates. Apoquel is a trademark of Zoetis
Services, LLC. © 2025 Elanco or its affiliates.
i AVMA Pet Ownership and Demographic Sourcebook
2022.
ii Elanco Animal Health. Data on File.
iii Elanco and FleishmanHillard TRUE Global
Intelligence Survey.
iv Elanco Animal Health. Data on File.
v Elanco Animal Health. Data on File.
Investor Contact: Tiffany Kanaga (765) 740-0314
tiffany.kanaga@elancoah.com
Media Contact: Season Solorio
(765) 316-0233 season.solorio@elancoah.com
View original
content:https://www.prnewswire.com/news-releases/meet-the-faces-of-zen-elancos-zenrelia-ilunocitinib-tablets-helps-allergic-dogs-get-back-to-normal-302360104.html
SOURCE Elanco Animal Health
